ENTERS MERGER AGREEMENT FOR CRM BUSINESS RESTRUCTURING
MICROPORT CARDIOFLOW WILL ACQUIRE CRM CAYMAN THROUGH MERGER
PRE-DEAL EQUITY VALUE OF CRM CAYMAN IS $680 MILLION
MICROPORT CARDIOFLOW TO ISSUE NEW SHARES TO CRM CAYMAN SHAREHOLDERS AT HK$1.35 PER SHARE
Further company coverage: 0853.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.